| CLASS | DRUG/TOX | LP7790-1 |
| COMPONENT | OLANZapine | LP18087-4 |
| PROPERTY | SCnc | LP6860-3 |
| TIME_ASPCT | Pt | LP6960-1 |
| SYSTEM | Ser/Plas | LP7576-4 |
| SCALE_TYP | Qn | LP7753-9 |
| parent | OLANZapine | Serum or Plasma | Drug toxicology | LP391336-7 |
| CLASSTYPE | Laboratory class | |
| ORDER_OBS | Both | |
| EXAMPLE_UNITS | nmol/L | |
| EXAMPLE_UCUM_UNITS | nmol/L | |
| UNITSREQUIRED | N |
| LONG_COMMON_NAME | en-US | OLANZapine [Moles/volume] in Serum or Plasma |
| LONG_COMMON_NAME | en-US | OLANZapine [Moles/volume] in Serum or Plasma |
| SHORTNAME | en-US | OLANZapine SerPl-sCnc |
| ConsumerName | en-US | OLANZapine, Blood |
| SHORTNAME | pt-BR | Olanzapine SerPl-sCnc |
| LONG_COMMON_NAME | fr-FR | Olanzapine [Moles/Volume] Sérum/Plasma ; Numérique |
| LONG_COMMON_NAME | nl-NL | Olanzapine [mol/volume] in serum of plasma |
| LONG_COMMON_NAME | es-MX | OLANZapine: Suero o Plasma : Punto temporal: Concentración de sustancias: Cuantitativo: |
LOINC Version: 2.77
FHIR